SPDR S&P Biotech ETF (XBI) Holdings $94.01 +0.84 (+0.90%) (As of 11/20/2024 ET) Add Compare Share Share Holdings Stock AnalysisChartDividendHeadlinesHoldingsOwnershipRatings Top 50 XBI HoldingsRankCompanyCurrent PriceWeightShares Held1INCYIncyte$71.05+0.7%3.10%3,071,0242UTHRUnited Therapeutics$364.33+1.0%2.85%575,6383GILDGilead Sciences$88.63+1.0%2.83%2,357,1214NTRANatera$167.88+3.6%2.56%1,542,9365ALNYAlnylam Pharmaceuticals$248.79+6.2%2.55%735,7936NBIXNeurocrine Biosciences$123.29+3.5%2.51%1,596,650 Get the Latest News and Ratings for XBI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for SPDR S&P Biotech ETF and its competitors with MarketBeat's FREE daily newsletter. 7VRTXVertex Pharmaceuticals$451.23+0.7%2.50%402,1618AMGNAmgen$287.87+2.8%2.34%587,0599INSMInsmed$72.67-1.4%2.32%2,614,49010SRPTSarepta Therapeutics$110.86+4.0%2.28%1,565,92311VKTXViking Therapeutics$51.53+0.0%2.28%2,925,13912ABBVAbbVie$167.74+0.7%2.17%1,005,05713MDGLMadrigal Pharmaceuticals$317.09+0.9%2.16%514,39014BIIBBiogen$156.00+0.4%2.13%997,82015BMRNBioMarin Pharmaceutical$62.56+1.0%1.89%2,299,06416EXASExact Sciences$52.70-2.3%1.89%2,978,20817CYTKCytokinetics$49.86-2.4%1.79%2,468,21318REGNRegeneron Pharmaceuticals$743.35-0.2%1.73%169,21119CRSPCRISPR Therapeutics$47.26+0.6%1.68%2,468,07220BPMCBlueprint Medicines$94.81+0.2%1.67%1,349,03921HALOHalozyme Therapeutics$45.76+2.1%1.62%2,139,71222MRNAModerna$36.94-0.9%1.51%2,858,71823TGTXTG Therapeutics$31.15+2.7%1.49%3,924,74624RVMDRevolution Medicines$57.07+1.1%1.45%1,934,93925RNAAvidity Biosciences$43.65+0.9%1.34%2,298,22226KRYSKrystal Biotech$178.10+0.1%1.28%528,34827ADMAADMA Biologics$21.37+3.6%1.25%4,506,80028EXELExelixis$34.65+0.7%1.14%2,549,82029ROIVRoivant Sciences$11.49+1.6%1.11%7,566,84830ALKSAlkermes$27.91+1.6%1.10%2,944,89431IONSIonis Pharmaceuticals$35.40+4.9%1.10%2,291,23832BHVNBiohaven$46.81+1.1%1.03%1,585,66533IOVAIovance Biotherapeutics$8.14-0.6%0.99%7,527,16934PCVXVaxcyte$85.96-1.3%0.95%743,55235TWSTTwist Bioscience$41.11-0.5%0.94%1,603,48736BBIOBridgeBio Pharma$23.04+2.2%0.91%2,805,04637APLSApellis Pharmaceuticals$27.49-5.2%0.86%2,353,30738ACLXArcellx$87.22-0.4%0.85%642,57339GERNGeron$3.99+5.3%0.84%16,415,31340CRNXCrinetics Pharmaceuticals$56.07+1.6%0.83%1,123,344This company will win the AI race (Ad)Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally critical role in supporting the most revolutionary technology the world’s ever seen… artificial intelligence. And without it, the entire AI industry would collapse. You must read this new presentation from Porter Stansberry.41BEAMBeam Therapeutics$24.49-3.2%0.81%2,156,73642AGIOAgios Pharmaceuticals$54.62+0.4%0.77%1,031,76343RXRXRecursion Pharmaceuticals$6.04-3.7%0.76%7,790,24644ACADACADIA Pharmaceuticals$16.27+0.4%0.75%3,294,02445RAREUltragenyx Pharmaceutical$46.40+2.8%0.71%1,134,31046IMVTImmunovant$26.17+3.8%0.68%1,756,23647DYNDyne Therapeutics$29.99+1.0%0.66%1,901,66048SWTXSpringWorks Therapeutics$37.44-1.3%0.66%1,591,96149PTCTPTC Therapeutics$41.96+6.6%0.65%1,167,30150NTLAIntellia Therapeutics$13.12-7.1%0.64%2,945,911 Geographic ExposureUnited States94.4%Switzerland1.6%Ireland1.3%Bermuda1.2%Virgin Islands, British1.0%Canada0.1%Currency ExposureUSD100.0%Sector ExposureHealth Care75.0%Consumer Discretionary1.3%Energy0.1%Industry ExposureBiotechnology67.5%Health Care Equipment & Supplies3.9%Health Care Providers & Services3.4%Distributors0.9%Diversified Consumer Services0.5%Renewable Energy0.1%SubIndustry ExposureBiotechnology67.3%Life Sciences Tools & Services3.5%Health Care Services3.4%Pharmaceuticals0.7%Health Care Equipment0.2%Health Care Supplies0.2%Renewable Energy Equipment0.1%Coupon Exposure4-60.1%Maturity Exposure5-100.1% Related Companies and Tools Related Companies IBB Portfolio Companies IHI Portfolio Companies IXJ Portfolio Companies IYH Portfolio Companies FHLC Portfolio Companies FXH Portfolio Companies FBT Portfolio Companies RYH Portfolio Companies RSPH Portfolio Companies LABU Portfolio Companies This page (NYSEARCA:XBI) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SPDR S&P Biotech ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share SPDR S&P Biotech ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
